Go Back   NeuroTalk Support Groups > >

Parkinson's Disease Tulip

Growth Factor promotes new neuron growth in mouse model and crosses BBB

Thread Tools Display Modes
Old 05-12-2008, 08:36 PM   #1
Senior Member
olsen's Avatar
Join Date: Aug 2006
Posts: 1,845
Default Growth Factor promotes new neuron growth in mouse model and crosses BBB


Growth Factor Promotes New Neuron Growth in Mouse Model of Parkinson's

A well-known growth factor has been shown to increase the growth of new neurons in mice induced to develop Parkinson's disease. The finding highlights a potential new therapy for the condition.

Newswise — Mice induced to develop Parkinson’s disease (PD) show an increase in the growth of new neurons after they are treated with a well known growth factor. The research, to be published May 16 in The Journal of Neuroscience, based on work by scientists at the Buck Institute, highlights a potential new therapy for this incurable, neurodegenerative disorder that affects 1.5 million Americans.

The mice, which developed Parkinson-like symptoms after they received the toxin MPTP (which causes PD in humans) were treated with fibroblast growth factor-2 (FGF-2), a naturally occurring protein that has been studied extensively for its neuroprotective properties. In the Buck study, the use of FGF-2 enhanced the neurogenesis, or growth of new neurons, that was already underway in the injured area of the brain. In addition, researchers began to see an increase in the cells that produce dopamine, the neurotransmitter implicated in PD.

“The fact that FGF-2 allowed these new neurons to develop in the principle site of cell loss in the disease is quite exciting,” said Buck faculty member and lead scientist Julie Andersen, PhD. “This suggests that administration of growth factors might be used therapeutically to replace dead or damaged cells. The next step in our research is to see whether treatment with FGF-2 results in any symptomatic improvement in the mice.”

Scientists at the Buck are currently researching FGF-2 as a potential treatment for Huntington’s disease, a fatal hereditary brain disorder that affects approximately 30,000 Americans. In partnership with Neurobiological Technologies, Inc. (NASDAQ: NTII), Buck researchers are seeking to create a form of FGF-2 for human clinical trials. The protein shows particular promise because it is able to cross the blood-brain barrier.

This most recent study highlights the interdisciplinary approach to research at the Buck Institute. This work built on earlier discoveries in the laboratory of David Greenberg, MD, PhD, which showed neurogenesis occurring in the brains of patients diagnosed with Alzheimer’s disease, and the laboratory of Lisa Ellerby, PhD, which showed that FGF-2 promoted new nerve growth and increased survival in mice genetically engineered to develop Huntington’s disease. The work as a whole emphasizes a research focus at the Buck Institute on efforts to enhance the brains ability to heal itself in the face of injury.

Joining Andersen in the study were Jun Peng, Lin Xie, Kunlin Jin, and David A. Greenberg, all of the Buck Institute.

The Buck Institute is an independent non-profit organization dedicated to extending the healthspan, the healthy years of each individual’s life. The National Institute of Aging designated the Buck a Nathan Shock Center of Excellence in the Biology of Aging, one of just five centers in the country. Buck Institute scientists work in an innovative, interdisciplinary setting to understand the mechanisms of aging and to discover new ways of detecting, preventing and treating age-related diseases such as Alzheimer’s and Parkinson’s disease, cancer, stroke, and arthritis. Collaborative research at the Institute is supported by genomics, proteomics and bioinformatics technology. For more information: www.buckinstitute.org.
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices.

~ Jean-Martin Charcot

The future is already here it's just not very evenly distributed. William Gibson
olsen is offline   Reply With Quote
"Thanks for this!" says:
imark3000 (05-13-2008), lou_lou (05-12-2008), ZucchiniFlower (05-12-2008)
Old 05-13-2008, 10:48 AM   #2
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
Default I wonder if it

is similar to Growth Factor transpalnted directly in the brain in the famous halted tryals ?
Born in 1943. Diagnosed with PD in 2006.
imark3000 is offline   Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
A Mouse Model of a Human Motor Neuron Disease BobbyB ALS News & Research 0 01-09-2008 03:54 PM
4. A Mouse Model of a Human Motor Neuron Disease BobbyB ALS News & Research 0 12-18-2007 09:00 PM
Nerve Growth Factor Mark._. Peripheral Neuropathy 1 11-02-2007 11:39 AM

All times are GMT -5. The time now is 06:31 PM.
Brought to you by the fine folks who publish mental health and psychology information at Psych Central Mental Health Forums

The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider. Always consult your doctor before trying anything you read here.

Powered by vBulletin • Copyright ©2000 - 2019, Jelsoft Enterprises Ltd.
Search Engine Optimisation provided by DragonByte SEO v2.0.31 (Lite) - vBulletin Mods & Addons Copyright © 2019 DragonByte Technologies Ltd.

All posts copyright their original authors Community Guidelines Terms of Use Privacy Policy